Methylation Profiling of Specific Genes in Ependymomas
- PMID: 34854470
- PMCID: PMC10508420
- DOI: 10.5146/tjpath.2021.01565
Methylation Profiling of Specific Genes in Ependymomas
Abstract
Objective: Ependymomas are neuroepithelial tumors of the central nervous system with heterogeneous biology and clinical course. The aim of the present study is to investigate the relationship between the methylation status and clinicopathological parameters in ependymomas.
Material and method: DNA methylation status of CDKN2A, RASSF1A, KLF4 and ZIC2 genes were quantitatively analyzed with pyrosequencing in 44 ependymoma tumor tissues. The relationship of methylation profiles with tumor subtype, histological grade and patient age was statistically analyzed.
Results: DNA methylation analyses for CDKN2A revealed no difference in methylation levels. Of the 31 included samples for optimal ZIC2 methylation analysis, 10 were hypermethylated (32.3%) and this change was significantly found in the adult spinal ependymomas (p=0.01). KLF4 hypermethylation was observed in 6 of the overall included 35 samples (17.1%); however, there was no statistically significant relation of the methylation status with tumor subtype, histological grade or age group. RASSF1A hypermethylation was observed in overall 40 included samples with varying methylation levels. Higher levels of hypermethylation were significantly related to the grade 3 histology (p=0.01) and spinal ependymomas (p=0.006). The pediatric cases with grade 3 ependymomas and ependymomas of adulthood showed significantly increased RASSF1A hypermethylation levels (p < 0.001 and p=0.001, respectively).
Conclusion: DNA methylation changes are likely to have biological importance in ependymomas. Both ZIC2 and RASSF1A methylation status may be useful parameters in the subclassification of these tumors.
Conflict of interest statement
None of the authors have any conflict of interest
Figures
Similar articles
-
Molecular characterization of histopathological ependymoma variants.Acta Neuropathol. 2020 Feb;139(2):305-318. doi: 10.1007/s00401-019-02090-0. Epub 2019 Nov 2. Acta Neuropathol. 2020. PMID: 31679042
-
Gene-Specific DNA Methylation Profiles in Pediatric Medulloblastomas.Pediatr Dev Pathol. 2022 Mar-Apr;25(2):82-90. doi: 10.1177/10935266211036680. Epub 2021 Sep 23. Pediatr Dev Pathol. 2022. PMID: 34554028
-
Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.Cancer Genet Cytogenet. 2006 Apr 1;166(1):74-81. doi: 10.1016/j.cancergencyto.2005.09.004. Cancer Genet Cytogenet. 2006. PMID: 16616114
-
Biology and management of ependymomas.Neuro Oncol. 2016 Jul;18(7):902-13. doi: 10.1093/neuonc/now016. Epub 2016 Mar 28. Neuro Oncol. 2016. PMID: 27022130 Free PMC article. Review.
-
Prognosis by tumor location in adults with spinal ependymomas.J Neurosurg Spine. 2013 Mar;18(3):226-35. doi: 10.3171/2012.12.SPINE12591. Epub 2013 Jan 11. J Neurosurg Spine. 2013. PMID: 23311515 Review.
References
-
- Korshunov Andrey, Witt Hendrik, Hielscher Thomas, Benner Axel, Remke Marc, Ryzhova Marina, Milde Till, Bender Sebastian, Wittmann Andrea, Schöttler Anna, Kulozik Andreas E., Witt Olaf, Deimling Andreas, Lichter Peter, Pfister Stefan. Molecular staging of intracranial ependymoma in children and adults. Jul;2010 J Clin Oncol. 28:3182–3190. doi: 10.1200/JCO.2009.27.3359. - DOI - PubMed
-
- Gatta Gemma, Botta Laura, Rossi Silvia, Aareleid Tiiu, Bielska-Lasota Magdalena, Clavel Jacqueline, Dimitrova Nadya, Jakab Zsuzsanna, Kaatsch Peter, Lacour Brigitte, Mallone Sandra, Marcos-Gragera Rafael, Minicozzi Pamela, Sánchez-Pérez Maria-José, Sant Milena, Santaquilani Mariano, Stiller Charles, Tavilla Andrea, Trama Annalisa, Visser Otto, Peris-Bonet Rafael, EUROCARE Working Group Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Jan;2014 Lancet Oncol. 15:35–47. doi: 10.1016/S1470-2045(13)70548-5. - DOI - PubMed
-
- Louis David N., Perry Arie, Wesseling Pieter, Brat Daniel J., Cree Ian A., Figarella-Branger Dominique, Hawkins Cynthia, Ng H. K., Pfister Stefan M., Reifenberger Guido, Soffietti Riccardo, Deimling Andreas, Ellison David W. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Aug;2021 Neuro Oncol. 23:1231–1251. doi: 10.1093/neuonc/noab106. - DOI - PMC - PubMed
-
- Neumann Julia E., Spohn Michael, Obrecht Denise, Mynarek Martin, Thomas Christian, Hasselblatt Martin, Dorostkar Mario M., Wefers Annika K., Frank Stephan, Monoranu Camelia-Maria, Koch Arend, Witt Hendrik, Kool Marcel, Pajtler Kristian W., Rutkowski Stefan, Glatzel Markus, Schüller Ulrich. Molecular characterization of histopathological ependymoma variants. Feb;2020 Acta Neuropathol. 139:305–318. doi: 10.1007/s00401-019-02090-0. - DOI - PubMed
-
- Pajtler Kristian W., Witt Hendrik, Sill Martin, Jones David T. W., Hovestadt Volker, Kratochwil Fabian, Wani Khalida, Tatevossian Ruth, Punchihewa Chandanamali, Johann Pascal, Reimand Jüri, Warnatz Hans-Jörg, Ryzhova Marina, Mack Steve, Ramaswamy Vijay, Capper David, Schweizer Leonille, Sieber Laura, Wittmann Andrea, Huang Zhiqin, Sluis Peter, Volckmann Richard, Koster Jan, Versteeg Rogier, Fults Daniel, Toledano Helen, Avigad Smadar, Hoffman Lindsey M., Donson Andrew M., Foreman Nicholas, Hewer Ekkehard, Zitterbart Karel, Gilbert Mark, Armstrong Terri S., Gupta Nalin, Allen Jeffrey C., Karajannis Matthias A., Zagzag David, Hasselblatt Martin, Kulozik Andreas E., Witt Olaf, Collins V. Peter, Hoff Katja, Rutkowski Stefan, Pietsch Torsten, Bader Gary, Yaspo Marie-Laure, Deimling Andreas, Lichter Peter, Taylor Michael D., Gilbertson Richard, Ellison David W., Aldape Kenneth, Korshunov Andrey, Kool Marcel, Pfister Stefan M. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. May;2015 Cancer Cell. 27:728–743. doi: 10.1016/j.ccell.2015.04.002. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous